ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025
Applications of generative adversarial networks in the diagnosis, prognosis, and treatment of ophthalmic diseases.
Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging Technologies for Exploring the Cellular Mechanisms in Vascular Diseases.International journal of molecular sciences · 2025Review
- The Role of Artificial Intelligence in Imaging-Based Diagnosis of Retinal Dystrophy and Evaluation of Gene Therapy Efficacy.Journal of personalized medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeGenerative adversarial networks (GANs) are key components of many artificial intelligence (AI) systems that are applied to image-informed bioengineering and medicine. GANs combat key limitations facing deep learning models: small, unbalanced datasets containing few images of severe disease. The predictive capacity of conditional GANs may also be extremely useful in managing disease on an individual basis. This narrative review focusses on the application of GANs in ophthalmology, in order to provide a critical account of the current state and ongoing challenges for healthcare professionals and allied scientists who are interested in this rapidly evolving field.
methodsWe performed a search of studies that apply generative adversarial networks (GANs) in diagnosis, therapy and prognosis of eight eye diseases. These disparate tasks were selected to highlight developments in GAN techniques, differences and common features to aid practitioners and future adopters in the field of ophthalmology.
resultsThe studies we identified show that GANs have demonstrated capacity to: generate realistic and useful synthetic images, convert image modality, improve image quality, enhance extraction of relevant features, and provide prognostic predictions based on input images and other relevant data.
conclusionThe broad range of architectures considered describe how GAN technology is evolving to meet different challenges (including segmentation and multi-modal imaging) that are of particular relevance to ophthalmology. The wide availability of datasets now facilitates the entry of new researchers to the field. However mainstream adoption of GAN technology for clinical use remains contingent on larger public datasets for widespread validation and necessary regulatory oversight.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.